Skip to main content
International Journal of Bipolar Disorders
Fig. 4 | International Journal of Bipolar Disorders

Fig. 4

From: A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder

Fig. 4

Kaplan–Meier survival estimates for TIME in patients with moderate/severe baseline mood symptoms. *The p values were calculated using the log-rank test and is for the PBO versus LTG comparison. Marks represent censored events. Estimates are for the RD FAP (excluding patients without baseline CGI-S or HAMD/YMRS scores). CGI-S, Clinical Global Impressions of Severity; FAP, full analysis population; HAMD, Hamilton Depression Rating Scale; LTG, Lamotrigine; PBO, Placebo; RD, randomised double-blind; TIME, time to intervention for a mood episode; YMRS, Young Mania Rating Scale

Back to article page